What can be distilled from the current literature is that early
disease frequently responds well to conservative management
and advanced disease commonly requires a radical resection and
reconstruction. Microvascular free tissue transfer plays an important
role in the management of advanced stage ORN. It is the intermediate
stage patients who often undergo multiple debridements
combined with HBO therapy, unfortunately, a subset will ultimately
require a radical resection and reconstruction.